Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Yet, according to Tahir Warraich, CEO of Fynite, the shift unfolding now is far more foundational. He explains that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback